![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12Q 1/68 |
(11) | Number of the document | 3353322 |
(13) | Kind of document | T |
(96) | European patent application number | 16774644.5 |
Date of filing the European patent application | 2016-09-23 | |
(97) | Date of publication of the European application | 2018-08-01 |
(45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2016/072723 |
Date | 2016-09-23 |
(87) | Number | WO 2017/050985 |
Date | 2017-03-30 |
(30) | Number | Date | Country code |
201531360 | 2015-09-23 | ES |
(72) |
MIRANDA UTRERA, Natalia, ES
VILLACAMPA AUB , Felipe, ES
CASTELLANO, Daniel, ES
FRESNO VARA, Juan ngel, ES
G MEZ POZO, Angelo, ES
|
(73) |
Fundaci n Para la Investigaci n Biomédica del Hospital Universitario de la Paz,
Paseo de la Castellana 261 Edificio Norte (Antigua Escuela de Enfermeras) 4 Planta, 28046 Madrid,
ES
Fundaci n para la Investigaci n Biomedica del Hospital 12 de Octubre, Avda. de C rdoba s/n CAA 6th Floor Planta Bloque, 28041 Madrid, ES |
(54) | PROGNOSTIC METHOD FOR DETERMINING THE RISK OF RELAPSE IN RENAL CANCER PATIENTS WITH A CLEAR CELL TYPE OF RENAL CARCINOMA, STAGES I AND II, AND KIT FOR SAME |
PROGNOSTIC METHOD FOR DETERMINING THE RISK OF RELAPSE IN RENAL CANCER PATIENTS WITH A CLEAR CELL TYPE OF RENAL CARCINOMA, STAGES I AND II, AND KIT FOR SAME |